BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAF8. A total of 40 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $7,875,000 | -0.5% | 6,000,000 | -20.0% | 0.36% | -11.4% |
| Q1 2020 | $7,916,000 | -0.1% | 7,500,000 | +2.7% | 0.40% | +25.5% |
| Q4 2019 | $7,920,000 | +5.2% | 7,300,000 | 0.0% | 0.32% | +0.3% |
| Q3 2019 | $7,528,000 | -8.4% | 7,300,000 | 0.0% | 0.32% | -11.1% |
| Q2 2019 | $8,214,000 | -1.1% | 7,300,000 | 0.0% | 0.36% | -4.8% |
| Q1 2019 | $8,303,000 | +2.3% | 7,300,000 | 0.0% | 0.38% | -10.2% |
| Q4 2018 | $8,119,000 | -7.2% | 7,300,000 | 0.0% | 0.42% | +6.0% |
| Q3 2018 | $8,749,000 | -7.1% | 7,300,000 | -9.9% | 0.40% | -15.5% |
| Q2 2018 | $9,414,000 | +287.2% | 8,100,000 | +268.2% | 0.47% | +267.2% |
| Q1 2018 | $2,431,000 | -35.5% | 2,200,000 | -37.1% | 0.13% | -68.0% |
| Q4 2013 | $3,769,000 | – | 3,500,000 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonora Investment Management, LLC | 5,590,000 | $6,433,196,000 | 1.48% |
| SHENKMAN CAPITAL MANAGEMENT INC | 12,450,000 | $14,458,000 | 1.24% |
| LINDEN ADVISORS LP | 20,760,000 | $24,046,000 | 1.05% |
| GUARDIAN LIFE INSURANCE CO OF AMERICA | 8,000,000 | $9,250,000 | 0.72% |
| Man Investments (CH) AG | 900,000 | $1,043,000 | 0.54% |
| Nicholas Investment Partners, LP | 6,600,000 | $7,631,000 | 0.53% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 28,035,000 | $32,497,000 | 0.50% |
| SSI INVESTMENT MANAGEMENT LLC | 2,067,000 | $2,389,000 | 0.23% |
| Calamos Advisors LLC | 23,382,000 | $27,088,000 | 0.19% |
| LOOMIS SAYLES & CO L P | 591,575 | $46,025,000 | 0.12% |